Back to Results
First PageMeta Content
HRPC / Satraplatin / GPC Biotech


Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and a Waiver under 21 U.S.C. $355 (n)(4) Pamela Haylock, R.N., M.A. Committee:
Add to Reading List

Document Date: 2007-07-09 08:23:20

Open Document

File Size: 25,17 KB

Share Result on Facebook

Company

Spectrum Pharmaceuticals / GPC Biotech AG / Johnson Matthey Pharmaceuticals / Johnson Matthey PLC / /

Currency

USD / /

MedicalCondition

prostate cancer / /

MedicalTreatment

chemotherapy / /

Organization

FDA / Oncologic Drugs Advisory Committee / M.A. Committee / /

Position

R.N. / /

Technology

chemotherapy / /

SocialTag